Trial Profile
EFFECT OF DIFFERENT MEALS ON THE PHARMACOKINETIC PROFILE OF SAQUINAVIR AT STEADY STATE IN HIV-INFECTED PATIENTS TREATED WITH SAQUINAVIR/RITONAVIR 1000/100 mg BID.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jul 2019
Price :
$35
*
At a glance
- Drugs Ritonavir (Primary) ; Saquinavir (Primary)
- Indications HIV-1 infections
- Focus Pharmacokinetics
- 27 Jul 2019 Status changed from recruiting to completed.
- 08 Jul 2011 New trial record